Article Information
History
- August 2, 2021.
Article Versions
- Version 1 (June 22, 2021 - 15:07).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- 1Department of Biosciences, University of Oslo, Norway
- 2Department of Informatics, University of Oslo, Norway
- 3Urology Research Laboratory, Department for BioMedical Research DBMR, University of Bern, Bern, Switzerland
- 4Institute of Basic Medical Sciences, Department of Molecular Medicine, University of Oslo, Norway
- 5PharmaTox Strategic Research Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Norway
- 6Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Norway
- ↵#Correspondence: Ankush.Sharma{at}medisin.uio.no and Ragnhild.Eskeland{at}medisin.uio.no